Diet for Hypoglycemia

Causes Of Hypoglycemia News

  • American, Canadian officials discuss global health developments at recent G8, G20 summits Friday, July 9, 2010 @ 12:23AMThe recent G8 summit in Canada's Muskoka region took an important step forward in improving maternal and child health in developing countries, Canadian and American officials said at a forum Wednesday in Washington, DC.
  • Artificial Pancreas: Next Step in Diabetes Fight? Monday, June 28, 2010 @ 10:20AMA closed-loop insulin delivery system -- the so-called "artificial pancreas" -- appears to improve glucose control in patients with type 1 diabetes even after a large dinner accompanied by wine, compared with insulin pump therapy, researchers said here. Diabetes mellitus type 1 - Insulin - Artificial pancreas - Pancreas - Health
  • Marcus Welby, M.D.: Season One Tuesday, May 4, 2010 @ 9:06PMHighly Recommended "How would you know what she needed? Except what you learned in text books and therapy manuals. She was just a 'case' to you. A chance to display your skills. I admit you have those skills. Now you have to learn medicine goes beyond technique and into human need. When you begin to search for that need as carefully as you search for the causes of illness, the cures...then you ...
  • Experts on JustAnswer(R) Share Five Life-Saving Pet Care Tips Monday, April 19, 2010 @ 1:08PMSAN FRANCISCO, April 19 /PRNewswire/ -- According to an American Pet Products Association (APPA) survey, 62 percent of U.S.
  • Experts on JustAnswer(R) Share Five Life-Saving Pet Care Tips Monday, April 19, 2010 @ 10:00AMAccording to an American Pet Products Association survey, 62 percent of U.S. households have a pet and more than half of all owners identify their pets as a member of their family. The survey also found that in 2009 Americans spent $45 billion on their pets â nearly half of that was for vet care, supplies and overâthe-counter medicines.
  • Avandia Debate "Skewed" By Pharmaceutical Company Sunday, March 21, 2010 @ 5:16AMResearchers claim that pharmaceutical company GlaxoSmithkline has tried to influence the debate on the safety of diabetes treatment drug Avandia, also known as rosiglitazone, which the company manufactures. A new study claims that more than nine out of ten scientists who backed the drug had financial links to the pharmaceutical industry. Researchers from the Mayo Clinic in Minnesota analysed ...
  • Report: Brittany Murphy Was Prescribed 200 Pills Per Month Saturday, March 20, 2010 @ 10:05AMLOS ANGELES -- Actress Brittany Murphy, who died in December at age 32, was getting at least 200 pills per month from January 2008 through August 2009, according to celebrity news outlet TMZ.
  • Lack of cellular enzyme triggers switch in glucose processing Wednesday, January 27, 2010 @ 12:25PMA study investigating how a cellular enzyme affects blood glucose levels in mice provides clues to pathways that may be involved in processes including the regulation of longevity and the proliferation of tumor cells. Researchers have described the mechanism by which absence of the enzyme SIRT6 induces a fatal drop in blood sugar in mice by triggering a switch between two critical cellular ...
  • Switch In Glucose Processing Triggered By Lack Of Cellular Enzyme Monday, January 25, 2010 @ 5:33AMA study investigating how a cellular enzyme affects blood glucose levels in mice provides clues to pathways that may be involved in processes including the regulation of longevity and the proliferation of tumor cells. In their report in the January 22 issue of Cell, a Massachusetts General Hospital (MGH)-based team of researchers describes the mechanism by which absence of the enzyme SIRT6 ...
  • Asylum seekers still face deportation threat Wednesday, December 16, 2009 @ 12:58PMAliran strongly urges the government to stop deportation of undocumented migrants some of whom could be asylum seekers qualifying for determination of their status as refugees by UNHCR.
  • Deaths/causes Aug. 6 — Sept. 7 | Public record Sunday, September 27, 2009 @ 4:34PMAbshier, Clinton C.; 79, Richland, Ind., Sept. 4, pancreatic cancer Alexander, Bessie Elaine; 60, Newburgh, Aug. 17, intracranial hemorrhage Bailey, Beulah P.; 84, Francisco, Ind., Sept. 2, carcinoma of the lung Barclay, Jack R.; 81, Odon, Ind., Aug. 17, sepsis Beach, Ronnie Dewayne; 56, Evansville, Aug. 30, respiratory failure, pneumonia Burnett, Marilou; 85, Evansville, Sept. 3 ...
  • LETTERS: Dementia and Hypoglycemic Episodes in Patients With Type 2 Diabetes Mellitus--Reply Tuesday, August 25, 2009 @ 3:36PMIn Reply: We agree with the general premise of Drs Graveling and Frier that caution is appropriate in observational studies of treatments and their consequences.
  • Experimental drug helping American diabetics Sunday, June 7, 2009 @ 6:42PMNovo Nordisk A/S's experimental diabetes drug liraglutide was significantly better at helping American patients control blood sugar than an older common medicine after two years of treatment
  • Novo diabetes drug tops older medicine at two years Sunday, June 7, 2009 @ 9:47AMNEW YORK (Reuters) - Novo Nordisk A/S's experimental diabetes drug liraglutide was significantly better at helping patients control blood sugar than an older common medicine after two years of treatment, according to data from a clinical trial.
  • (AFX UK Focus) 2009-06-07 15:15 Novo diabetes drug tops older medicine at 2 years Sunday, June 7, 2009 @ 9:46AMBy Bill Berkrot
  • Interim Analysis of Long-Term Data with ONGLYZA (saxagliptin) When Added to Metformin in People with Inadequately ... Saturday, June 6, 2009 @ 10:13AMResults from an interim analysis of a long-term Phase 3 study at 102 weeks with ONGLYZA (saxagliptin), an investigational, selective, ...
  • Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of ... Saturday, June 6, 2009 @ 10:13AMResults from a 12-week study demonstrated that the investigational drug dapagliflozin, a novel, selective, sodium glucose co-transporter 2 ...
  • Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of ... Saturday, June 6, 2009 @ 10:00AMPRINCETON, N.J. & WILMINGTON, Del.----Results from a 12-week study demonstrated that the investigational drug dapagliflozin, a novel, selective, sodium glucose co-transporter 2 inhibitor, produced greater improvements across all key glycemic measures studied [glycosylated hemoglobin level , fasting plasma glucose and post-prandial glucose ] in type 2 diabetes patients who were treated with high ...
  • Interim Analysis of Long-Term Data with ONGLYZA (saxagliptin) When Added to Metformin in People with Inadequately ... Saturday, June 6, 2009 @ 10:00AMPRINCETON, N.J. & WILMINGTON, Del.----Results from an interim analysis of a long-term Phase 3 study at 102 weeks with ONGLYZA™ , an investigational, selective, reversible inhibitor of the dipeptidyl peptidase-4 enzyme under joint development by Bristol-Myers Squibb Company and AstraZeneca , when added to metformin in people with inadequately controlled type 2 diabetes, demonstrated an overall ...
  • CGM Devices Also Benefit People With Type 1 Diabetes Who Already Have Good Blood Sugar Control Thursday, May 28, 2009 @ 10:21AMPeople with type 1 diabetes who have already been successful in achieving recommended blood sugar goals can further benefit from using continuous glucose monitoring (CGM) devices, according to results of a major multi-center clinical trial by the Juvenile Diabetes Research Foundation. Findings of the study were published online by the journal Diabetes Care, available here.
  • Glucose monitoring devices benefit people with type 1 diabetes Wednesday, May 27, 2009 @ 2:49PMPeople with type 1 diabetes who have already been successful in achieving recommended blood sugar goals can further benefit from using continuous glucose monitoring (CGM) devices, according to results of a major multi-center clinical trial by the Juvenile Diabetes Research Foundation. Findings of the study were published online by the journal Diabetes Care.
  • Study shows CGM devices also benefit people with type 1 diabetes Wednesday, May 27, 2009 @ 2:13PM( Juvenile Diabetes Research Foundation International ) People with type 1 diabetes who have already been successful in achieving recommended blood sugar goals can further benefit from using continuous glucose monitoring (CGM) devices, according to results of a major multicenter clinical trial by the Juvenile Diabetes Research Foundation.
  • Diabetes May Contribute To Dementia, Study Finds Tuesday, April 14, 2009 @ 6:28PMResearchers say there is now evidence that both high and low blood sugar levels may promote the development of dementia in the elderly.
  • Low Blood Sugar May Increase Risk for Dementia Tuesday, April 14, 2009 @ 4:24PMDiabetes may raise the risk for dementia in older adults, new research finds. Previous studies have suggested that high blood sugar can raise the odds of dementia, and now a new study finds low blood sugar may have the same effect.
  • Hypoglycemia linked to dementia Tuesday, April 14, 2009 @ 10:29AMSevere low blood sugar episodes might heighten risk in later years